Monoclonal antibodies are among the most promising treatments for mild to moderate COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.

Monoclonal antibodies are just like your body's antibodies but selected for their strong ability to resist the virus. They are produced like a medication and help your body fight illness. In 2020, the Food and Drug Administration issued an emergency use authorization to permit monoclonal antibodies as a treatment option for COVID-19. If you are also suffering from covid-19 then you can get the monoclonal antibody treatment in Miami via http://cbyelitecare.com/Monoclonal-Antibody-Treatment/.

After entering your body, monoclonal antibodies look for and attach to the spike protein that sticks out of the coronavirus that causes COVID-19. When monoclonal antibodies attach to the spike protein, they can block the virus's ability to enter cells — and slow down the infection.

In 2020, the FDA authorized several different monoclonal antibodies to treat COVID-19. Monoclonal antibodies is a treatment given in an outpatient clinic through an IV/needle in your arm or it may be several shots given during one visit, that should help to keep your symptoms from getting worse. Research studies show that it should be effective at preventing COVID-19 symptoms from becoming severe and that patients who receive the treatment are less likely to get sicker leading to an Emergency Department visit or needing to be admitted to the hospital.